|Daily Range||$92.51 - $95.73|
|52-Week Range||$70.19 - $116.65|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||794,732|
|Current FY EPS||$7.81|
How do you think UTHR
will perform against the market?
Top UTHR Bull/Bear Pitches
healthcarevalue (< 20)
Submitted July 24, 2013
UTHR, United Therapeutics Corp, safe debt/equity ratio of 0.24, Return on Invested Capital (ROIC) twelve trailing months of 20.88 and from 2012 of even higher at 23.42, trailing price/earnings ratio a … More
Submitted October 4, 2006
New PAH drugs will reduce UTHR's market; generic Flolan, Ambrisentan etc.
News & Commentary
United Therapeutics Corp (UTHR) Description
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. Website: http://www.unither.com/